Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Lindsey Graham says ‘strong consensus’ to protect Kurds...
Senate Dems revolt against DHS funding bill amid...
Lindsey Graham says there’s ‘strong consensus’ to protect...
JOSH HAMMER: Case against Israel cheapens the word...
Trump hails ‘great and very brave’ UK soldiers...
Key Senator won’t fund DHS as ICE, federal...
Trump says it ‘is too late’ to stop...
Trump pushes ‘Trump-a-palooza’ midterm convention as GOP braces...
Chaos in Syria sparks fears of ISIS prison...
Trump warns Canada of 100% tariffs if it...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

Trump picks Dr. Marty Makary as Food and Drug Administration commissioner

by admin November 23, 2024
November 23, 2024
Trump picks Dr. Marty Makary as Food and Drug Administration commissioner

President-elect Trump on Friday announced he is nominating Johns Hopkins School of Medicine professor Dr. Marty Makary for Food and Drug Administration (FDA) commissioner. 

‘I am very pleased to nominate Marty Makary MD, MPH, FACS, for FDA Commissioner,’ Trump said in a statement. ‘FDA has lost the trust of Americans, and has lost sight of its primary goal as a regulator. The Agency needs Dr. Marty Makary, a Highly Respected Johns Hopkins Surgical Oncologist and Health Policy Expert, to course-correct and refocus the Agency.’ 

Makary’s nomination comes after Trump nominated Robert F. Kennedy, Jr. to lead the Department of Health and Human Services (HHS) to ‘Make America healthy again.’

Trump said Makary will ‘work under the leadership of Robert F. Kennedy Jr. to, among other things, properly evaluate harmful chemicals poisoning our Nation’s food supply and drugs and biologics being given to our Nation’s youth, so that we can finally address the Childhood Chronic Disease Epidemic.’ 

Trump in his statement added that Makary, who was a Fox News medical contributor, is also a ‘member of the prestigious National Academy of Medicine’ and ‘has devoted his career to improving Medical Quality and lowering Hospital and Drug Costs for all Americans. In addition, Dr. Makary is an accomplished Professor at the Johns Hopkins School of Medicine and Johns Hopkins Carey Business School, and a leading advocate for Healthcare Transparency. He has authored more than 300 scientific articles and three New York Times bestselling books on Healthcare.

Trump called Makary a ‘pioneer in the fields of Public Health, Cancer Care, and Surgery, and a tireless voice for vulnerable populations. He is the recipient of the Nobility in Science Award from the National Pancreas Foundation and numerous teaching awards. Dr. Makary currently leads the Evidence-Based Medicine and Public Policy Research Group at Johns Hopkins.’

He added, ‘I am confident that Dr. Makary, having dedicated his career to High-Quality, Lower-Cost Care, will restore FDA to the Gold Standard of Scientific Research, and cut the bureaucratic red tape at the Agency to make sure Americans get the Medical Cures and Treatments they deserve.’

Trump made several other announcements Friday evening as he continues his transition, including Dr. Janette Nesheiwat as surgeon general, and Dr. Dave Weldon to head the U.S. Centers for Disease Control and Prevention (CDC). 

This post appeared first on FOX NEWS

previous post
Trump picks Scott Turner as secretary for Department of Housing and Urban Development
next post
From CDC to labor secretary: See Trump’s top picks for Cabinet roles

You may also like

New Republican Governors Association chair says ‘focus’ is...

November 21, 2024

Trump accuses Senate Democrats of using nominee confirmations...

August 4, 2025

Senate Majority Leader Thune says this is the...

February 14, 2025

House Oversight probes whether American retirees’ pension funds...

September 23, 2025

Senate in limbo as Thune eyes long haul...

November 9, 2025

White House orders Hegseth to stop polygraphs on...

July 28, 2025

‘Radical Left’ shutdown message ignites firestorm as Democrats...

November 17, 2025

SEN. JEANNE SHAHEEN: If Trump wants a Ukraine...

May 29, 2025

Zelenskyy wants details after Trump-Putin call, lays out...

March 19, 2025

Trump calls for death penalty for suspect in...

September 10, 2025

Recent Posts

  • Lindsey Graham says ‘strong consensus’ to protect Kurds as Syrian forces advance on territory
  • Senate Dems revolt against DHS funding bill amid Minneapolis chaos, hiking government shutdown risk
  • Lindsey Graham says there’s ‘strong consensus’ to protect Kurds as Syrian forces advance on territory
  • JOSH HAMMER: Case against Israel cheapens the word ‘genocide’
  • Trump hails ‘great and very brave’ UK soldiers after slamming NATO allies’ Afghanistan service

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (967)
    • Investing (3,947)
    • Politics (4,772)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 Sightful Invest. All Rights Reserved.